These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 39085407)

  • 1. Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy.
    Zeng YY; Gu Q; Li D; Li AX; Liu RM; Liang JY; Liu JY
    Acta Pharmacol Sin; 2024 Dec; 45(12):2455-2473. PubMed ID: 39085407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy.
    Zhong Z; Deng W; Wu J; Shang H; Tong Y; He Y; Huang Q; Ba X; Chen Z; Tang K
    Nanoscale; 2024 May; 16(18):8708-8738. PubMed ID: 38634521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boosting Checkpoint Immunotherapy with Biomimetic Nanodrug Delivery Systems.
    Chen W; Tang C; Chen G; Li J; Li N; Zhang H; Di L; Wang R
    Adv Healthc Mater; 2024 Jun; 13(14):e2304284. PubMed ID: 38319961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy.
    Liu H; Lu Y; Zong J; Zhang B; Li X; Qi H; Yu T; Li Y
    J Nanobiotechnology; 2024 Oct; 22(1):663. PubMed ID: 39465376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment.
    Han X; Gong C; Yang Q; Zheng K; Wang Z; Zhang W
    Int J Nanomedicine; 2024; 19():571-608. PubMed ID: 38260239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of targeted drug delivery by cell membrane-based biomimetic nanoparticles for inflammatory diseases and cancers.
    Qiu S; Zhu F; Tong L
    Eur J Med Res; 2024 Oct; 29(1):523. PubMed ID: 39472940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
    Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy.
    Li J; Zeng H; Li L; Yang Q; He L; Dong M
    ACS Nano; 2023 Dec; 17(24):24593-24618. PubMed ID: 38055350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in nanomedicine delivery systems: unraveling immune regulation strategies for tumor immunotherapy.
    Zhang Y; Chen X; Hu B; Zou B; Xu Y
    Nanomedicine (Lond); 2024; 19(21-22):1821-1840. PubMed ID: 39011582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance.
    Xu Z; Zhou H; Li T; Yi Q; Thakur A; Zhang K; Ma X; Qin JJ; Yan Y
    Drug Resist Updat; 2024 Jul; 75():101098. PubMed ID: 38833804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
    Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
    Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication.
    Mengyuan H; Aixue L; Yongwei G; Qingqing C; Huanhuan C; Xiaoyan L; Jiyong L
    J Nanobiotechnology; 2024 Oct; 22(1):604. PubMed ID: 39370518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Composite Biofilm Biomimetic Nanodrug Delivery Systems for Cancer Treatment.
    Meng Y; Chen S; Wang C; Ni X
    Technol Cancer Res Treat; 2024; 23():15330338241250244. PubMed ID: 38693842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics.
    Zhang M; Cheng S; Jin Y; Zhang N; Wang Y
    Clin Transl Med; 2021 Feb; 11(2):e292. PubMed ID: 33635002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
    Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
    Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment.
    Zhao G; Wang S; Nie G; Li N
    Med; 2024 Jul; 5(7):660-688. PubMed ID: 38582088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic Nanoscale Systems for Targeted Delivery in Cancer: Current Advances and Future Prospects.
    Singh D; Poonia N
    Curr Drug Metab; 2024; 25(6):403-415. PubMed ID: 39238377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment.
    Gu Y; Du L; Wu Y; Qin J; Gu X; Guo Z; Li Y
    Biomolecules; 2024 Aug; 14(8):. PubMed ID: 39199348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cells based nanotheranostics: A smart biomimetic approach for fighting against cancer.
    Misra R; Sanjana Sharath N
    Int J Pharm; 2024 Aug; 661():124401. PubMed ID: 38986966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.